Press "Enter" to skip to content

Natco dares Novartis with new heart drug

According to data from AIOCD PharmaTrac, an agency that closely tracks pharmaceutical sales, Vymada had sales of Rs 68.3 crore for December 2018 on the moving annual turnover (MAT).

Original source: https://health.economictimes.indiatimes.com/news/pharma/natco-dares-novartis-with-new-heart-drug/67749672?utm_source=RSS&utm_medium=ETRSS

Also Read:   Serum Institute pauses Covid vax trials in India